NFE2L2 and ischemic stroke: In TBI and ischemic stroke, Nrf2 activation limits NF-κB (nuclear factor kappa B)–driven proinflammatory responses, reducing secretion of cytokines such as TNF-α, IL-1β, and IL-6 (interleukin 1β, 6) [104].